Investors Snag NLTX 8.1% Cheaper Than Its Secondary Stock Offering
July 06, 2020 at 09:58 AM EDT
Looking back to 4 days ago, Neoleukin Therapeutics Inc (NLTX) priced a 3,262,471 share secondary stock offering at $15.25 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..
